Chemokine receptor oligomerization and allostery

Progress in Molecular Biology and Translational Science

Volumn 115, Issue , 2013, Pages 375-420

  Stephens, Bryan ^a   Handel, Tracy M ^a  

^a UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

Author keywords

Allostery; CCR2; CCR5; Chemokine receptor; CXCR2; CXCR4; CXCR7; DARC; Dimerization; G protein coupled receptor; Keywords; Oligomerization

Indexed keywords

EID: 84873926627     PISSN: 18771173     EISSN: None     Source Type: Book Series    
DOI: 10.1016/B978-0-12-394587-7.00009-9     Document Type: Chapter

References (129)

1. L.M. Munoz, P. Lucas, B.L. Holgado, R. Barroso, B. Vega, and J.M. Rodriguez-Frade Receptor oligomerization: a pivotal mechanism for regulating chemokine function Pharmacol Ther 131 2011 351 358
2. C.L. Salanga, and T.M. Handel Chemokine oligomerization and interactions with receptors and glycosaminoglycans: the role of structural dynamics in function Exp Cell Res 317 2011 590 601
3. L.M. Munoz, B.L. Holgado, A.C. Martinez, J.M. Rodriguez-Frade, and M. Mellado Chemokine receptor oligomerization: a further step toward chemokine function Immunol Lett 145 2012 23 29
4. D.J. Scholten, M. Canals, D. Maussang, L. Roumen, M.J. Smit, and M. Wijtmans Pharmacological modulation of chemokine receptor function Br J Pharmacol 165 2012 1617 1643
5. G.J. Graham D6 and the atypical chemokine receptor family: novel regulators of immune and inflammatory processes Eur J Immunol 39 2009 342 351
6. G.J. Graham, M. Locati, A. Mantovani, A. Rot, and M. Thelen The biochemistry and biology of the atypical chemokine receptors Immunol Lett 145 2012 30 38
7. I. Kalatskaya, Y.A. Berchiche, S. Gravel, B.J. Limberg, J.S. Rosenbaum, and N. Heveker AMD3100 is a CXCR7 ligand with allosteric agonist properties Mol Pharmacol 75 2009 1240 1247
8. B.A. Zabel, S. Lewen, R.D. Berahovich, J.C. Jaen, and T.J. Schall The novel chemokine receptor CXCR7 regulates trans-endothelial migration of cancer cells Mol Cancer 10 2011 73
9. V. Odemis, J. Lipfert, R. Kraft, P. Hajek, G. Abraham, and K. Hattermann The presumed atypical chemokine receptor CXCR7 signals through G(i/o) proteins in primary rodent astrocytes and human glioma cells Glia 60 2012 372 381
10. T.J. Schall, and A.E. Proudfoot Overcoming hurdles in developing successful drugs targeting chemokine receptors Nat Rev Immunol 11 2011 355 363
11. N.W. Lukacs, S.H. Oliveira, and C.M. Hogaboam Chemokines and asthma: redundancy of function or a coordinated effort? J Clin Invest 104 1999 995 999
12. A. Mantovani The chemokine system: redundancy for robust outputs Immunol Today 20 1999 254 257
13. A.E. Proudfoot, C.A. Power, and M.K. Schwarz Anti-chemokine small molecule drugs: a promising future? Expert Opin Investig Drugs 19 2010 345 355
14. M.N. Devalaraja, and A. Richmond Multiple chemotactic factors: fine control or redundancy? Trends Pharmacol Sci 20 1999 151 156
15. T.M. Handel, and E.K. Lau Chemokine structure and receptor interactions Ernst Scher Res Found Workshop 45 2004 101 124
16. P. Ray, S.A. Lewin, L.A. Mihalko, S.C. Lesher-Perez, S. Takayama, and K.E. Luker Secreted CXCL12 (SDF-1) forms dimers under physiological conditions Biochem J 442 2012 433 442
17. M. Ren, Q. Guo, L. Guo, M. Lenz, F. Qian, and R.R. Koenen Polymerization of MIP-1 chemokine (CCL3 and CCL4) and clearance of MIP-1 by insulin-degrading enzyme EMBO J 29 2010 3952 3966
18. X. Wang, C. Watson, J.S. Sharp, T.M. Handel, and J.H. Prestegard Oligomeric structure of the chemokine CCL5/RANTES from NMR, MS, and SAXS data Structure 19 2011 1138 1148
19. A.J. Hoogewerf, G.S. Kuschert, A.E. Proudfoot, F. Borlat, I. Clark-Lewis, and C.A. Power Glycosaminoglycans mediate cell surface oligomerization of chemokines Biochemistry 36 1997 13570 13578
20. E.K. Lau, C.D. Paavola, Z. Johnson, J.P. Gaudry, E. Geretti, and F. Borlat Identification of the glycosaminoglycan binding site of the CC chemokine, MCP-1: implications for structure and function in vivo J Biol Chem 279 2004 22294 22305
21. B. Vega, L.M. Munoz, B.L. Holgado, P. Lucas, J.M. Rodriguez-Frade, and A. Calle Technical advance: surface plasmon resonance-based analysis of CXCL12 binding using immobilized lentiviral particles J Leukoc Biol 90 2011 399 408
22. L. Wang, M. Fuster, P. Sriramarao, and J.D. Esko Endothelial heparan sulfate deficiency impairs L-selectin- and chemokine-mediated neutrophil trafficking during inflammatory responses Nat Immunol 6 2005 902 910
23. X. Yin, J. Truty, R. Lawrence, S.C. Johns, R.S. Srinivasan, and T.M. Handel A critical role for lymphatic endothelial heparan sulfate in lymph node metastasis Mol Cancer 9 2010 316
24. A.E. Proudfoot, T.M. Handel, Z. Johnson, E.K. Lau, P. LiWang, and I. Clark-Lewis Glycosaminoglycan binding and oligomerization are essential for the in vivo activity of certain chemokines Proc Natl Acad Sci USA 100 2003 1885 1890
25. K. Rajarathnam, B.D. Sykes, C.M. Kay, B. Dewald, T. Geiser, and M. Baggiolini Neutrophil activation by monomeric interleukin-8 Science 264 1994 90 92
26. I. Clark-Lewis, K.S. Kim, K. Rajarathnam, J.H. Gong, B. Dewald, and B. Moser Structure-Activity relationships of chemokines J Leukoc Biol 57 1995 703 711
27. Y. Zhang, and B.J. Rollins A dominant negative inhibitor indicates that monocyte chemoattractant protein 1 functions as a dimer Mol Cell Biol 15 1995 4851 4855
28. A.E. Proudfoot, C.A. Power, A.J. Hoogewerf, M.O. Montjovent, F. Borlat, and R.E. Offord Extension of recombinant human RANTES by the retention of the initiating methionine produces a potent antagonist J Biol Chem 271 1996 2599 2603
29. K. Jarnagin, D. Grunberger, M. Mulkins, B. Wong, S. Hemmerich, and C. Paavola Identification of surface residues of the monocyte chemotactic protein 1 that affect signaling through the receptor CCR2 Biochemistry 38 1999 16167 16177
30. M.P. Crump, J.H. Gong, P. Loetscher, K. Rajarathnam, A. Amara, and F. Arenzana-Seisdedos Solution structure and basis for functional activity of stromal cell-derived factor-1; dissociation of CXCR4 activation from binding and inhibition of HIV-1 EMBO J 16 1997 6996 7007
31. K.Y. Blain, W. Kwiatkowski, Q. Zhao, D. La Fleur, C. Naik, and T.W. Chun Structural and functional characterization of CC chemokine CCL14 Biochemistry 46 2007 10008 10015
32. E. Brandt, J. Van Damme, and H.D. Flad Neutrophils can generate their activator neutrophil-Activating peptide 2 by proteolytic cleavage of platelet-derived connective tissue-Activating peptide III Cytokine 3 1991 311 321
33. M. Mack, B. Luckow, P.J. Nelson, J. Cihak, G. Simmons, and P.R. Clapham Aminooxypentane-RANTES induces CCR5 internalization but inhibits recycling: a novel inhibitory mechanism of HIV infectivity J Exp Med 187 1998 1215 1224
34. H. Gaertner, F. Cerini, J.M. Escola, G. Kuenzi, A. Melotti, and R. Offord Highly potent, fully recombinant anti-HIV chemokines: reengineering a low-cost microbicide Proc Natl Acad Sci USA 105 2008 17706 17711
35. C.T. Veldkamp, C. Seibert, F.C. Peterson, N.B. De la Cruz, J.C. Haugner 3rd, and H. Basnet Structural basis of CXCR4 sulfotyrosine recognition by the chemokine SDF-1/CXCL12 Sci Signal 1 2008 ra4
36. C. Blanpain, B.J. Doranz, A. Bondue, C. Govaerts, A. De Leener, and G. Vassart The core domain of chemokines binds CCR5 extracellular domains while their amino terminus interacts with the transmembrane helix bundle J Biol Chem 278 2003 5179 5187
37. Y. Kofuku, C. Yoshiura, T. Ueda, H. Terasawa, T. Hirai, and S. Tominaga Structural basis of the interaction between chemokine stromal cell-derived factor-1/CXCL12 and its G-protein-coupled receptor CXCR4 J Biol Chem 284 2009 35240 35250
38. A.J. Kuszak, S. Pitchiaya, J.P. Anand, H.I. Mosberg, N.G. Walter, and R.K. Sunahara Purification and functional reconstitution of monomeric mu-opioid receptors: allosteric modulation of agonist binding by Gi2 J Biol Chem 284 2009 26732 26741
39. M.R. Whorton, M.P. Bokoch, S.G. Rasmussen, B. Huang, R.N. Zare, and B. Kobilka A monomeric G protein-coupled receptor isolated in a high-density lipoprotein particle efficiently activates its G protein Proc Natl Acad Sci USA 104 2007 7682 7687
40. M.R. Whorton, B. Jastrzebska, P.S. Park, D. Fotiadis, A. Engel, and K. Palczewski Efficient coupling of transducin to monomeric rhodopsin in a phospholipid bilayer J Biol Chem 283 2008 4387 4394
41. T.H. Bayburt, S.A. Vishnivetskiy, M.A. McLean, T. Morizumi, C.C. Huang, and J.J. Tesmer Monomeric rhodopsin is sufficient for normal rhodopsin kinase (GRK1) phosphorylation and arrestin-1 binding J Biol Chem 286 2011 1420 1428
42. J.M. Rodriguez-Frade, A.J. Vila-Coro, A.M. de Ana, J.P. Albar, A.C. Martinez, and M. Mellado The chemokine monocyte chemoattractant protein-1 induces functional responses through dimerization of its receptor CCR2 Proc Natl Acad Sci USA 96 1999 3628 3633
43. M. Mellado, J.M. Rodriguez-Frade, A.J. Vila-Coro, A.M. de Ana, and A.C. Martinez Chemokine control of HIV-1 infection Nature 400 1999 723 724
44. M. Mellado, J.M. Rodriguez-Frade, A.J. Vila-Coro, S. Fernandez, A. Martin de Ana, and D.R. Jones Chemokine receptor homo- or heterodimerization activates distinct signaling pathways EMBO J 20 2001 2497 2507
45. Y. Percherancier, Y.A. Berchiche, I. Slight, R. Volkmer-Engert, H. Tamamura, and N. Fujii Bioluminescence resonance energy transfer reveals ligand-induced conformational changes in CXCR4 homo- and heterodimers J Biol Chem 280 2005 9895 9903
46. Y.A. Berchiche, S. Gravel, M.E. Pelletier, G. St-Onge, and N. Heveker Different effects of the different natural CC chemokine receptor 2b ligands on beta-Arrestin recruitment, Galphai signaling, and receptor internalization Mol Pharmacol 79 2011 488 498
47. L. El-Asmar, J.Y. Springael, S. Ballet, E.U. Andrieu, G. Vassart, and M. Parmentier Evidence for negative binding cooperativity within CCR5-CCR2b heterodimers Mol Pharmacol 67 2005 460 469
48. J.Y. Springael, P.N. Le Minh, E. Urizar, S. Costagliola, G. Vassart, and M. Parmentier Allosteric modulation of binding properties between units of chemokine receptor homo- and hetero-oligomers Mol Pharmacol 69 2006 1652 1661
49. D. Sohy, H. Yano, P. de Nadai, E. Urizar, A. Guillabert, and J.A. Javitch Hetero-oligomerization of CCR2, CCR5, and CXCR4 and the protean effects of "selective" antagonists J Biol Chem 284 2009 31270 31279
50. M. Benkirane, D.Y. Jin, R.F. Chun, R.A. Koup, and K.T. Jeang Mechanism of transdominant inhibition of CCR5-mediated HIV-1 infection by ccr5delta32 J Biol Chem 272 1997 30603 30606
51. A.J. Vila-Coro, M. Mellado, A. Martin de Ana, P. Lucas, G. del Real, and A.C. Martinez HIV-1 infection through the CCR5 receptor is blocked by receptor dimerization Proc Natl Acad Sci USA 97 2000 3388 3393
52. J.M. Rodriguez-Frade, A.J. Vila-Coro, A. Martin, M. Nieto, F. Sanchez-Madrid, and A.E. Proudfoot Similarities and differences in RANTES- and (AOP)-RANTES-triggered signals: implications for chemotaxis J Cell Biol 144 1999 755 765
53. M. Chelli, and M. Alizon Determinants of the trans-dominant negative effect of truncated forms of the CCR5 chemokine receptor J Biol Chem 276 2001 46975 46982
54. C. Blanpain, J.M. Vanderwinden, J. Cihak, V. Wittamer, E. Le Poul, and H. Issafras Multiple active states and oligomerization of CCR5 revealed by functional properties of monoclonal antibodies Mol Biol Cell 13 2002 723 737
55. H. Issafras, S. Angers, S. Bulenger, C. Blanpain, M. Parmentier, and C. Labbe-Jullie Constitutive agonist-independent CCR5 oligomerization and antibody-mediated clustering occurring at physiological levels of receptors J Biol Chem 277 2002 34666 34673
56. R.L. Contento, B. Molon, C. Boularan, T. Pozzan, S. Manes, and S. Marullo CXCR4-CCR5: a couple modulating T cell functions Proc Natl Acad Sci USA 105 2008 10101 10106
57. M. Chelli, and M. Alizon Rescue of HIV-1 receptor function through cooperation between different forms of the CCR5 chemokine receptor J Biol Chem 277 2002 39388 39396
58. P. Hernanz-Falcon, J.M. Rodriguez-Frade, A. Serrano, D. Juan, A. del Sol, and S.F. Soriano Identification of amino acid residues crucial for chemokine receptor dimerization Nat Immunol 5 2004 216 223
59. J. Lemay, S. Marullo, R. Jockers, M. Alizon, and A. Brelot On the dimerization of CCR5 Nat Immunol 6 2005 535 Author reply 535-536
60. F. Huttenrauch, B. Pollok-Kopp, and M. Oppermann G protein-coupled receptor kinases promote phosphorylation and beta-Arrestin-mediated internalization of CCR5 homo- and hetero-oligomers J Biol Chem 280 2005 37503 37515
61. M.M. Hammad, Y.Q. Kuang, R. Yan, H. Allen, and D.J. Dupre Na +/H + exchanger regulatory factor-1 is involved in chemokine receptor homodimer CCR5 internalization and signal transduction but does not affect CXCR4 homodimer or CXCR4-CCR5 heterodimer J Biol Chem 285 2010 34653 34664
62. N. Charette, P. Holland, J. Frazer, H. Allen, and D.J. Dupre Dependence on different Rab GTPases for the trafficking of CXCR4 and CCR5 homo or heterodimers between the endoplasmic reticulum and plasma membrane in Jurkat cells Cell Signal 23 2011 1738 1749
63. Y.Q. Kuang, N. Charette, J. Frazer, P.J. Holland, K.M. Attwood, and G. Dellaire Dopamine receptor-interacting protein 78 acts as a molecular chaperone for CCR5 chemokine receptor signaling complex organization PLoS One 7 2012 e40522
64. S. Wilson, G. Wilkinson, and G. Milligan The CXCR1 and CXCR2 receptors form constitutive homo- and heterodimers selectively and with equal apparent affinities J Biol Chem 280 2005 28663 28674
65. L. Martinez Munoz, P. Lucas, G. Navarro, A.I. Checa, R. Franco, and A.C. Martinez Dynamic regulation of CXCR1 and CXCR2 homo- and heterodimers J Immunol 183 2009 7337 7346
66. F. Trettel, S. Di Bartolomeo, C. Lauro, M. Catalano, M.T. Ciotti, and C. Limatola Ligand-independent CXCR2 dimerization J Biol Chem 278 2003 40980 40988
67. C. Limatola, S. Di Bartolomeo, M. Catalano, F. Trettel, S. Fucile, and L. Castellani Cysteine residues are critical for chemokine receptor CXCR2 functional properties Exp Cell Res 307 2005 65 75
68. A.J. Vila-Coro, J.M. Rodriguez-Frade, A. Martin De Ana, M.C. Moreno-Ortiz, A.C. Martinez, and M. Mellado The chemokine SDF-1alpha triggers CXCR4 receptor dimerization and activates the JAK/STAT pathway FASEB J 13 1999 1699 1710
69. G.J. Babcock, M. Farzan, and J. Sodroski Ligand-independent dimerization of CXCR4, a principal HIV-1 coreceptor J Biol Chem 278 2003 3378 3385
70. F.F. Hamdan, Y. Percherancier, B. Breton, and M. Bouvier Monitoring protein-protein interactions in living cells by bioluminescence resonance energy transfer (BRET) Curr Protoc Neurosci 2006 Chapter 5, Unit 5 23
71. B. Lagane, K.Y. Chow, K. Balabanian, A. Levoye, J. Harriague, and T. Planchenault CXCR4 dimerization and beta-Arrestin-mediated signaling account for the enhanced chemotaxis to CXCL12 in WHIM syndrome Blood 112 2008 34 44
72. T. Tanaka, W. Nomura, T. Narumi, A. Masuda, and H. Tamamura Bivalent ligands of CXCR4 with rigid linkers for elucidation of the dimerization state in cells J Am Chem Soc 132 2010 15899 15901
73. W.T. Choi, S. Kumar, N. Madani, X. Han, S. Tian, and C.Z. Dong A novel synthetic bivalent ligand to probe chemokine receptor CXCR4 dimerization and inhibit HIV-1 entry Biochemistry 51 2012 7078 7086
74. P.T. Toth, D. Ren, and R.J. Miller Regulation of CXCR4 receptor dimerization by the chemokine SDF-1alpha and the HIV-1 coat protein gp120: a fluorescence resonance energy transfer (FRET) study J Pharmacol Exp Ther 310 2004 8 17
75. J. Wang, L. He, C.A. Combs, G. Roderiquez, and M.A. Norcross Dimerization of CXCR4 in living malignant cells: control of cell migration by a synthetic peptide that reduces homologous CXCR4 interactions Mol Cancer Ther 5 2006 2474 2483
76. M. Hamatake, T. Aoki, Y. Futahashi, E. Urano, N. Yamamoto, and J. Komano Ligand-independent higher-order multimerization of CXCR4, a G-protein-coupled chemokine receptor involved in targeted metastasis Cancer Sci 100 2009 95 102
77. K.E. Luker, M. Gupta, and G.D. Luker Imaging chemokine receptor dimerization with firefly luciferase complementation FASEB J 23 2009 823 834
78. A. Levoye, K. Balabanian, F. Baleux, F. Bachelerie, and B. Lagane CXCR7 heterodimerizes with CXCR4 and regulates CXCL12-mediated G protein signaling Blood 113 2009 6085 6093
79. M.A. Zhukovsky, S. Basmaciogullari, B. Pacheco, L. Wang, N. Madani, and H. Haim Thermal stability of the human immunodeficiency virus type 1 (HIV-1) receptors, CD4 and CXCR4, reconstituted in proteoliposomes PLoS One 5 2010 e13249
80. B. Wu, E.Y. Chien, C.D. Mol, G. Fenalti, W. Liu, and V. Katritch Structures of the CXCR4 chemokine GPCR with small-molecule and cyclic peptide antagonists Science 330 2010 1066 1071
81. D. Rodriguez, and H. Gutierrez-de-Teran Characterization of the homodimerization interface and functional hotspots of the CXCR4 chemokine receptor Proteins 80 2012 1919 1928
82. S. Asano, K. Kitatani, M. Taniguchi, M. Hashimoto, K. Zama, and S. Mitsutake Regulation of cell migration by sphingomyelin synthases: sphingomyelin in lipid rafts decreases responsiveness to signaling by the CXCL12/CXCR4 pathway Mol Cell Biol 32 2012 3242 3252
83. A. Chakera, R.M. Seeber, A.E. John, K.A. Eidne, and D.R. Greaves The duffy antigen/receptor for chemokines exists in an oligomeric form in living cells and functionally antagonizes CCR5 signaling through hetero-oligomerization Mol Pharmacol 73 2008 1362 1370
84. P.R. Gouldson, M.K. Dean, C.R. Snell, R.P. Bywater, G. Gkoutos, and C.A. Reynolds Lipid-facing correlated mutations and dimerization in G-protein coupled receptors Protein Eng 14 2001 759 767
85. J.M. Rodriguez-Frade, G. del Real, A. Serrano, P. Hernanz-Falcon, S.F. Soriano, and A.J. Vila-Coro Blocking HIV-1 infection via CCR5 and CXCR4 receptors by acting in trans on the CCR2 chemokine receptor EMBO J 23 2004 66 76
86. N. Vazquez-Salat, N. Yuhki, T. Beck, S.J. O'Brien, and W.J. Murphy Gene conversion between mammalian CCR2 and CCR5 chemokine receptor genes: a potential mechanism for receptor dimerization Genomics 90 2007 213 224
87. H.B. See, R.M. Seeber, M. Kocan, K.A. Eidne, and K.D. Pfleger Application of G protein-coupled receptor-heteromer identification technology to monitor beta-Arrestin recruitment to G protein-coupled receptor heteromers Assay Drug Dev Technol 9 2011 21 30
88. D. Sohy, M. Parmentier, and J.Y. Springael Allosteric transinhibition by specific antagonists in CCR2/CXCR4 heterodimers J Biol Chem 282 2007 30062 30069
89. N. Isik, D. Hereld, and T. Jin Fluorescence resonance energy transfer imaging reveals that chemokine-binding modulates heterodimers of CXCR4 and CCR5 receptors PLoS One 3 2008 e3424
90. J. Wang, R. Alvarez, G. Roderiquez, E. Guan, and M.A. Norcross Constitutive association of cell surface CCR5 and CXCR4 in the presence of CD4 J Cell Biochem 93 2004 753 760
91. F. Sierro, C. Biben, L. Martinez-Munoz, M. Mellado, R.M. Ransohoff, and M. Li Disrupted cardiac development but normal hematopoiesis in mice deficient in the second CXCL12/SDF-1 receptor, CXCR7 Proc Natl Acad Sci USA 104 2007 14759 14764
92. F.M. Decaillot, M.A. Kazmi, Y. Lin, S. Ray-Saha, T.P. Sakmar, and P. Sachdev CXCR7/CXCR4 heterodimer constitutively recruits beta-Arrestin to enhance cell migration J Biol Chem 286 2011 32188 32197
93. S. Mustafa, H.B. See, R.M. Seeber, S.P. Armstrong, C.W. White, and S. Ventura Identification and profiling of novel alpha1A-Adrenoceptor-CXC chemokine receptor 2 heteromer J Biol Chem 287 2012 12952 12965
94. S. Suzuki, L.F. Chuang, P. Yau, R.H. Doi, and R.Y. Chuang Interactions of opioid and chemokine receptors: oligomerization of mu, kappa, and delta with CCR5 on immune cells Exp Cell Res 280 2002 192 200
95. C. Chen, J. Li, G. Bot, I. Szabo, T.J. Rogers, and L.Y. Liu-Chen Heterodimerization and cross-desensitization between the mu-opioid receptor and the chemokine CCR5 receptor Eur J Pharmacol 483 2004 175 186
96. Y. Yuan, C.K. Arnatt, G. Li, K.M. Haney, D. Ding, and J.C. Jacob Design and synthesis of a bivalent ligand to explore the putative heterodimerization of the mu opioid receptor and the chemokine receptor CCR5 Org Biomol Chem 10 2012 2633 2646
97. M. Catalano, F. Trettel, R. Cipriani, C. Lauro, F. Sobrero, and F. Eusebi Chemokine CXCL8 modulates GluR1 phosphorylation J Neuroimmunol 198 2008 75 81
98. G. Parenty, S. Appelbe, and G. Milligan CXCR2 chemokine receptor antagonism enhances DOP opioid receptor function via allosteric regulation of the CXCR2-DOP receptor heterodimer Biochem J 412 2008 245 256
99. O.M. Pello, L. Martinez-Munoz, V. Parrillas, A. Serrano, J.M. Rodriguez-Frade, and M.J. Toro Ligand stabilization of CXCR4/delta-opioid receptor heterodimers reveals a mechanism for immune response regulation Eur J Immunol 38 2008 537 549
100. H.F. Vischer, S. Nijmeijer, M.J. Smit, and R. Leurs Viral hijacking of human receptors through heterodimerization Biochem Biophys Res Commun 377 2008 93 97
101. S. Nijmeijer, R. Leurs, M.J. Smit, and H.F. Vischer The Epstein-Barr virus-encoded G protein-coupled receptor BILF1 hetero-oligomerizes with human CXCR4, scavenges Galphai proteins, and constitutively impairs CXCR4 functioning J Biol Chem 285 2010 29632 29641
102. R. Barroso, L. Martinez Munoz, S. Barrondo, B. Vega, B.L. Holgado, and P. Lucas EBI2 regulates CXCL13-mediated responses by heterodimerization with CXCR5 FASEB J 26 2012 4841 4854
103. A. Kumar, T.D. Humphreys, K.N. Kremer, P.S. Bramati, L. Bradfield, and C.E. Edgar CXCR4 physically associates with the T cell receptor to signal in T cells Immunity 25 2006 213 224
104. X. Xiao, L. Wu, T.S. Stantchev, Y.R. Feng, S. Ugolini, and H. Chen Constitutive cell surface association between CD4 and CCR5 Proc Natl Acad Sci USA 96 1999 7496 7501
105. I.I. Singer, S. Scott, D.W. Kawka, J. Chin, B.L. Daugherty, and J.A. DeMartino CCR5, CXCR4, and CD4 are clustered and closely apposed on microvilli of human macrophages and T cells J Virol 75 2001 3779 3790
106. E. Doumazane, P. Scholler, J.M. Zwier, E. Trinquet, P. Rondard, and J.P. Pin A new approach to analyze cell surface protein complexes reveals specific heterodimeric metabotropic glutamate receptors FASEB J 25 2011 66 77
107. H.F. Vischer, A.O. Watts, S. Nijmeijer, and R. Leurs G protein-coupled receptors: walking hand-in-hand, talking hand-in-hand? Br J Pharmacol 163 2011 246 260
108. I. Kufareva, B. Stephens, C.T. Gilliland, B. Wu, G. Fenalti, and D. Hamel Novel approach to quantify GPCR dimerization equilibrium using bioluminescence resonance energy transfer Methods Mol Biol 2012 In press
109. J.A. Hern, A.H. Baig, G.I. Mashanov, B. Birdsall, J.E. Corrie, and S. Lazareno Formation and dissociation of M1 muscarinic receptor dimers seen by total internal reflection fluorescence imaging of single molecules Proc Natl Acad Sci USA 107 2010 2693 2698
110. G. Milligan G protein-coupled receptor hetero-dimerization: contribution to pharmacology and function Br J Pharmacol 158 2009 5 14
111. K.A. Jones, B. Borowsky, J.A. Tamm, D.A. Craig, M.M. Durkin, and M. Dai GABA(B) receptors function as a heteromeric assembly of the subunits GABA(B)R1 and GABA(B)R2 Nature 396 1998 674 679
112. J.H. White, A. Wise, M.J. Main, A. Green, N.J. Fraser, and G.H. Disney Heterodimerization is required for the formation of a functional GABA(B) receptor Nature 396 1998 679 682
113. L.J. Drury, J.J. Ziarek, S. Gravel, C.T. Veldkamp, T. Takekoshi, and S.T. Hwang Monomeric and dimeric CXCL12 inhibit metastasis through distinct CXCR4 interactions and signaling pathways Proc Natl Acad Sci USA 108 2011 17655 17660
114. G. Milligan, S. Wilson, and J.F. Lopez-Gimenez The specificity and molecular basis of alpha1-Adrenoceptor and CXCR chemokine receptor dimerization J Mol Neurosci 26 2005 161 168
115. N.I. Tarasova, W.G. Rice, and C.J. Michejda Inhibition of G-protein-coupled receptor function by disruption of transmembrane domain interactions J Biol Chem 274 1999 34911 34915
116. M. Chabre, P. Deterre, and B. Antonny The apparent cooperativity of some GPCRs does not necessarily imply dimerization Trends Pharmacol Sci 30 2009 182 187
117. N.J. Birdsall Class A GPCR heterodimers: evidence from binding studies Trends Pharmacol Sci 31 2010 499 508
118. B. Molon, G. Gri, M. Bettella, C. Gomez-Mouton, A. Lanzavecchia, and A.C. Martinez T cell costimulation by chemokine receptors Nat Immunol 6 2005 465 471
119. M. Pruenster, and A. Rot Throwing light on DARC Biochem Soc Trans 34 2006 1005 1008
120. B.A. Zabel, Y. Wang, S. Lewen, R.D. Berahovich, M.E. Penfold, and P. Zhang Elucidation of CXCR7-mediated signaling events and inhibition of CXCR4-mediated tumor cell transendothelial migration by CXCR7 ligands J Immunol 183 2009 3204 3211
121. K.E. Luker, S.A. Lewin, L.A. Mihalko, B.T. Schmidt, J.S. Winkler, and N.L. Coggins Scavenging of CXCL12 by CXCR7 promotes tumor growth and metastasis of CXCR4-positive breast cancer cells Oncogene 45 2012 4750 4758
122. D. Maussang, H.F. Vischer, A. Schreiber, D. Michel, and M.J. Smit Pharmacological and biochemical characterization of human cytomegalovirus- encoded G protein-coupled receptors Methods Enzymol 460 2009 151 171
123. E. Slinger, E. Langemeijer, M. Siderius, H.F. Vischer, and M.J. Smit Herpesvirus-encoded GPCRs rewire cellular signaling Mol Cell Endocrinol 331 2011 179 184
124. J.L. Hsu, and S.L. Glaser Epstein-barr virus-Associated malignancies: epidemiologic patterns and etiologic implications Crit Rev Oncol Hematol 34 2000 27 53
125. T. Miyagi, L.F. Chuang, K.M. Lam, H. Kung, J.M. Wang, and B.I. Osburn Opioids suppress chemokine-mediated migration of monkey neutrophils and monocytes - an instant response Immunopharmacology 47 2000 53 62
126. T.A. Kohout, S.L. Nicholas, S.J. Perry, G. Reinhart, S. Junger, and R.S. Struthers Differential desensitization, receptor phosphorylation, beta-Arrestin recruitment, and ERK1/2 activation by the two endogenous ligands for the CC chemokine receptor 7 J Biol Chem 279 2004 23214 23222
127. T. Baltus, K.S. Weber, Z. Johnson, A.E. Proudfoot, and C. Weber Oligomerization of RANTES is required for CCR1-mediated arrest but not CCR5-mediated transmigration of leukocytes on inflamed endothelium Blood 102 2003 1985 1988
128. J. Vinet, M. van Zwam, I.M. Dijkstra, N. Brouwer, H.R. van Weering, and A. Watts Inhibition of CXCR3-mediated chemotaxis by the human chemokine receptor-like protein CCX-CKR Br J Pharmacol 2012 Epub ahead of print
129. A.O. Watts, M.M. van Lipzig, W.C. Jaeger, R.M. Seeber, M. van Zwam, and J. Vinet Identification and profiling of CXCR3-CXCR4 chemokine receptor heteromer complexes Br J Pharmacol 2012 Epub ahead of print